Expanding the reach ofAntibody-Based Therapiesto more cancers,more diseases,more lives
Our science
Targeted therapies to transform cancer treatment
Our patented antibody technology targets a cancer-specific marker, attacking tumors with precision while sparing healthy cells. By combining precision targeting with the flexibility to support multiple treatment formats, this distinctive platform is designed to deliver safer, more effective therapies for some of the most aggressive cancers.
Let's advance cancer treatment together
Interested in partnering with us, learning more about our platform, or exploring investment opportunities?
We'd love to hear from you.